(VIANEWS) – Shares of Horizon Therapeutics (NASDAQ: HZNP) fell 8.27% to $86.89 at 10:49 EST on Wednesday, after five successive sessions in a row of losses. NASDAQ is dropping 0.95% to $12,444.78, after two consecutive sessions in a row of gains. This seems, up to now, a somewhat bearish trend exchanging session today.
Horizon Therapeutics’s last close was $94.72, 21.42% below its 52-week high of $120.54.
Today’s last reported volume for Horizon Therapeutics is 2075095 which is 15.8% above its average volume of 1791906.
Horizon Therapeutics’s Sales
Horizon Therapeutics’s sales growth is 34.1% for the present quarter and 177.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 14.8% and 4300%, respectively.
Horizon Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 36.1%, now sitting on 3.23B for the twelve trailing months.
Horizon Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.09%, a negative 0.56%, and a positive 1.43%, respectively.
Horizon Therapeutics’s highest amplitude of average volatility was 2.09% (last week), 1.59% (last month), and 1.43% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Horizon Therapeutics’s stock is considered to be overbought (>=80).
Horizon Therapeutics’s Stock Yearly Top and Bottom Value
Horizon Therapeutics’s stock is valued at $86.89 at 10:49 EST, way below its 52-week high of $120.54 and above its 52-week low of $83.42.
Horizon Therapeutics’s Moving Average
Horizon Therapeutics’s worth is way below its 50-day moving average of $104.54 and way under its 200-day moving average of $104.53.
More news about Horizon Therapeutics (HZNP).